STAA Shares Outstanding History
Below is a table of the STAA shares outstanding history going back to 3/29/2010:

Date STAA Shares Outstanding
3/29/201034.87M
3/30/201030.02M
5/10/201034.91M
8/10/201034.95M
11/8/201035.02M
3/1/201135.27M
4/29/201135.54M
7/29/201135.67M
10/25/201136.10M
3/2/201236.20M
4/27/201236.44M
7/27/201236.49M
10/31/201236.60M
3/1/201336.64M
4/30/201336.75M
8/2/201336.99M
10/25/201337.30M
2/28/201437.97M
5/6/201438.39M
7/24/201438.59M
10/26/201438.65M
3/11/201538.80M
5/1/201538.85M
7/24/201539.80M
10/23/201539.89M
2/26/201640.16M
5/4/201640.19M
7/29/201640.43M
10/24/201640.61M
2/20/201740.75M
4/28/201740.93M
7/24/201741.11M
10/30/201741.16M
2/20/201841.42M
4/27/201841.62M
7/27/201841.90M
10/26/201844.13M
2/18/201944.21M
4/26/201944.47M
7/26/201944.54M
6/30/201951.46M
10/25/201944.61M
2/20/202044.96M
5/1/202045.11M
7/31/202045.81M
10/30/202046.11M
2/19/202146.56M
4/30/202146.90M

Also see: STAA Market Cap History
STAA YTD Return
STAA Historical Shares Outstanding:
+2.71% CAGR
STAA Historical Shares Outstanding: +2.71% CAGR

Mouse over chart for data details
3/29/2010 ...4/30/2021
STAAR Surgical designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. Co. is a manufacturer of lenses used worldwide in corrective or refractive surgery. Co.'s principal products are implantable Collamer lenses (ICLs) used in refractive surgery and intraocular lenses (IOLs) used in cataract surgery. ICLs, consisting of Co.'s ICL family of products, including the Toric implantable Collamer lenses and EVO+ Visian ICL, are intraocular lenses used to correct refractive conditions. IOLs are prosthetic intraocular lenses used to restore vision that has been affected by cataracts. We show 48 historical shares outstanding datapoints in our coverage of STAA's shares outstanding history.

Understanding the changing numbers of STAA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like STAA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching STAA by allowing them to research STAA shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for STAA:
STAA SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Staar Surgical (STAA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

STE Shares Outstanding History
STEM Shares Outstanding History
STML Shares Outstanding History
SUPN Shares Outstanding History
SVA Shares Outstanding History
SVRA Shares Outstanding History
SYBX Shares Outstanding History
SYK Shares Outstanding History
SYRS Shares Outstanding History
TARO Shares Outstanding History
More Healthcare companies »

 

STAA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.